KMT5A and diffuse large B-cell lymphoma: Consistently, our analysis of the TCGA dataset revealed that COP1 was associated with better overall survival in DLBCL patients (P < 0.05), while KMT5A predicted poorer prognosis (Fig. 7h-i).